Augmented Reality in Pediatric Septic Shock Simulation: Randomized Controlled Feasibility Trial

被引:3
|
作者
Toto, Regina L. [1 ]
Vorel, Ethan S. [1 ]
Tay, Khoon-Yen E. [1 ]
Good, Grace L. [1 ]
Berdinka, Jesse M. [2 ]
Peled, Adam [2 ]
Leary, Marion [3 ]
Chang, Todd P. [4 ]
Weiss, Anna K. [1 ]
Balamuth, Frances B. [1 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] BrickSimple LLC, Doylestown, PA USA
[3] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA
[4] Childrens Hosp Los Angeles, Div Emergency Med & Transport, Los Angeles, CA 90027 USA
来源
JMIR MEDICAL EDUCATION | 2021年 / 7卷 / 04期
关键词
augmented reality; simulation; septic shock; children; pediatrics; simulation-based education; application; fluid administration; CAMPAIGN INTERNATIONAL GUIDELINES; VIRTUAL-REALITY; MANAGEMENT; SEPSIS;
D O I
10.2196/29899
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Background: Septic shock is a low-frequency but high-stakes condition in children requiring prompt resuscitation, which makes it an important target for simulation-based education. Objective: In this study, we aimed to design and implement an augmented reality app (PediSepsisAR) for septic shock simulation, test the feasibility of measuring the timing and volume of fluid administration during septic shock simulation with and without PediSepsisAR, and describe PediSepsisAR as an educational tool. We hypothesized that we could feasibly measure our desired data during the simulation in 90% of the participants in each group. With regard to using PediSepsisAR as an educational tool, we hypothesized that the PediSepsisAR group would report that it enhanced their awareness of simulated patient blood flow and would more rapidly verbalize recognition of abnormal patient status and desired management steps. Methods: We performed a randomized controlled feasibility trial with a convenience sample of pediatric care providers at a large tertiary care pediatric center. Participants completed a prestudy questionnaire and were randomized to either the PediSepsisAR or control (traditional simulation) arms. We measured the participants' time to administer 20, 40, and 60 cc/kg of intravenous fluids during a septic shock simulation using each modality. In addition, facilitators timed how long participants took to verbalize they had recognized tachycardia, hypotension, or septic shock and desired to initiate the sepsis pathway and administer antibiotics. Participants in the PediSepsisAR arm completed a poststudy questionnaire. We analyzed data using descriptive statistics and a Wilcoxon rank-sum test to compare the median time with event variables between groups. Results: We enrolled 50 participants (n=25 in each arm). The timing and volume of fluid administration were captured in all the participants in each group. There was no statistically significant difference regarding time to administration of intravenous fluids between the two groups. Similarly, there was no statistically significant difference between the groups regarding time to verbalized recognition of patient status or desired management steps. Most participants in the PediSepsisAR group reported that PediSepsisAR enhanced their awareness of the patient's perfusion. Conclusions: We developed an augmented reality app for use in pediatric septic shock simulations and demonstrated the feasibility of measuring the volume and timing of fluid administration during simulation using this modality. In addition, our findings suggest that PediSepsisAR may enhance participants' awareness of abnormal perfusion.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] EFFECTS OF SHENFU INJECTION ON SUBLINGUAL MICROCIRCULATION IN SEPTIC SHOCK PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Wang, Shiwei
    Liu, Guoxiang
    Chen, Li
    Xu, Xinhui
    Jia, Tianyuan
    Zhu, Changqing
    Xiong, Jianfei
    SHOCK, 2022, 58 (03): : 196 - 203
  • [42] Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial
    Petsakul, Suttasinee
    Morakul, Sunthiti
    Tangsujaritvijit, Viratch
    Kunawut, Parinya
    Singhatas, Pongsasit
    Sanguanwit, Pitsucha
    BMC ANESTHESIOLOGY, 2020, 20 (01)
  • [43] Lung ultrasound–guided fluid resuscitation in neonatal septic shock: A randomized controlled trial
    Dabin Huang
    Chuming You
    Xiaowei Mai
    Lin Li
    Qiong Meng
    Zhenyu Liang
    European Journal of Pediatrics, 2024, 183 : 1255 - 1263
  • [44] Role of dexmedetomidine in modifying immune paralysis in patients with septic shock: randomized controlled trial
    Mohamed Elayashy
    Eman A. Elsayed
    Ahmed M. Mukhtar
    Sahar Kasem
    Sara A. Elmetwally
    Sara Habib
    Walaa Abdelfattah
    Doaa Ghaith
    Amr Hussein
    Intensive Care Medicine Experimental, 11
  • [45] Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial
    Arabi, Yaseen M.
    Aljumah, Abdulrahman
    Dabbagh, Ousama
    Tamim, Hani M.
    Rishu, Asgar H.
    Al-Abdulkareem, Abdulmajeed
    Al Knawy, Bandar
    Hajeer, Ali H.
    Tamimi, Waleed
    Cherfan, Antoine
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) : 1971 - 1977
  • [46] Triiodothyronine Administration in a Model of Septic Shock: A Randomized Blinded Placebo-Controlled Trial
    Maiden, Matthew J.
    Chapman, Marianne J.
    Torpy, David J.
    Kuchel, Timothy R.
    Clarke, Iain J.
    Nash, Coralie H.
    Fraser, Jonathan D.
    Ludbrook, Guy L.
    CRITICAL CARE MEDICINE, 2016, 44 (06) : 1153 - 1160
  • [47] Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial
    Bruno François
    Xavier Wittebole
    Ricard Ferrer
    Jean-Paul Mira
    Thierry Dugernier
    Sébastien Gibot
    Marc Derive
    Aurélie Olivier
    Valérie Cuvier
    Stephan Witte
    Peter Pickkers
    François Vandenhende
    Jean-Jacques Garaud
    Miguel Sánchez
    Margarita Salcedo-Magguilli
    Pierre-François Laterre
    Intensive Care Medicine, 2020, 46 : 1425 - 1437
  • [48] Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial
    Meng, Jian-biao
    Hu, Ma-hong
    Lai, Zhi-zhen
    Ji, Chun-lian
    Xu, Xiu-juan
    Zhang, Geng
    Tian, Shuyuan
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1486 - 1496
  • [49] Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial
    Francois, Bruno
    Wittebole, Xavier
    Ferrer, Ricard
    Mira, Jean-Paul
    Dugernier, Thierry
    Gibot, Sebastien
    Derive, Marc
    Olivier, Aurelie
    Cuvier, Valerie
    Witte, Stephan
    Pickkers, Peter
    Vandenhende, Francois
    Garaud, Jean-Jacques
    Sanchez, Miguel
    Salcedo-Magguilli, Margarita
    Laterre, Pierre-Francois
    INTENSIVE CARE MEDICINE, 2020, 46 (07) : 1425 - 1437
  • [50] TREATMENT OF SEPTIC SHOCK WITH A PROTEASE INHIBITOR IN A CANINE MODEL - A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL
    TANI, T
    AOKI, H
    YOSHIOKA, T
    LIN, KJ
    KODAMA, M
    CRITICAL CARE MEDICINE, 1993, 21 (06) : 925 - 930